Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Hypoxia Signaling

Background:

• Ischemic cardiomyopathy is a primary cause of heart failure, marked by left ventricular dysfunction disproportionate to infarct size.
• The precise mechanisms linking reduced oxygen/nutrient delivery to impaired contractility are not fully understood.
• Prolyl Hydroxylase Domain-Containing Proteins (PHDs) are oxygen sensors regulating hypoxia-inducible factor (HIF) stability.

Purpose of the Study:

• To investigate the role of PHD enzymes in the pathogenesis of ischemic cardiomyopathy.
• To determine if impaired PHD activity and subsequent HIF activation contribute to cardiac dysfunction.

Main Methods:

• Cardiac-specific inactivation of PHD enzymes in a mouse model.
• Long-term expression of a stabilized HIF-alpha variant in cardiomyocytes.

Main Results:

• Cardiac-specific PHD inactivation led to ultrastructural, histological, and functional changes resembling ischemic cardiomyopathy.
• Sustained expression of stabilized HIF-alpha in cardiomyocytes resulted in dilated cardiomyopathy.

Conclusions:

• Sustained loss of PHD activity and consequent HIF activation are sufficient to induce changes seen in ischemic cardiomyopathy.
• These findings implicate PHD-HIF pathway dysregulation in the cardiac remodeling associated with chronic ischemia and coronary artery disease.